News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
485,072 Results
Type
Article (8036)
Company Profile (140)
Press Release (476895)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166740)
Career Advice (304)
Deals (25738)
Drug Delivery (7)
Drug Development (52873)
Employer Resources (14)
FDA (9761)
Job Trends (8572)
News (238195)
Policy (17900)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (6)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (488)
Accelerated approval (24)
ADA (18)
Adcomms (1)
Allergies (97)
Alliances (33161)
ALS (105)
Alzheimer's disease (978)
Antibody-drug conjugate (ADC) (272)
Approvals (10391)
Artificial intelligence (323)
ASCO (159)
Autoimmune disease (207)
Automation (28)
Bankruptcy (263)
Best Places to Work (6963)
BIO (36)
Biologics (2)
BIOSECURE Act (1)
Biosimilars (112)
BioSpace Insights (17)
Biotechnology (88)
Bladder cancer (139)
Brain cancer (29)
Breast cancer (514)
Cancer (3679)
Cardiovascular disease (221)
Career advice (246)
Career pathing (1)
CAR-T (175)
CDMO (7)
Celiac Disease (1)
Cell therapy (479)
Cervical cancer (34)
Clinical research (47921)
Collaboration (1253)
Commercialization (3)
Compensation (1474)
Complete response letters (34)
COVID-19 (759)
CRISPR (64)
C-suite (758)
Cystic fibrosis (85)
Data (5712)
Denatured (4)
Depression (102)
Dermatology (63)
Diabetes (344)
Diagnostics (4192)
Digital health (39)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (156)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (164)
Earnings (73729)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (87707)
Executive appointments (703)
FDA (12425)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (18)
Frontotemporal dementia (23)
Funding (927)
Gene editing (126)
Generative AI (9)
Gene therapy (321)
GLP-1 (291)
Government (954)
Grass and pollen (2)
Guidances (281)
Healthcare (9339)
Hematology (94)
HIV (53)
Huntington's disease (22)
IgA nephropathy (64)
Immunology and inflammation (98)
Immuno-oncology (59)
Indications (157)
Infectious disease (947)
Inflammatory bowel disease (126)
Inflation Reduction Act (4)
Influenza (84)
Intellectual property (258)
Interviews (42)
IPO (12388)
IRA (2)
Job creations (1968)
Job search strategy (235)
JPM (1)
Kidney cancer (16)
Layoffs (59)
Legal (5210)
Licensing (11)
Liver cancer (44)
Longevity (18)
Lung cancer (512)
Lymphoma (253)
Machine learning (27)
Management (3)
Manufacturing (538)
Marketing (8)
MASH (118)
Medical device (8665)
Medtech (8812)
Mergers & acquisitions (14392)
Metabolic disorders (709)
mRNA (59)
Multiple sclerosis (103)
NASH (4)
Neurodegenerative disease (220)
Neuropsychiatric disorders (40)
Neuroscience (1833)
NextGen: Class of 2026 (3153)
Non-profit (847)
Obesity (225)
Opinion (10)
Ovarian cancer (159)
Pain (172)
Pancreatic cancer (201)
Parkinson's disease (201)
Partnered (12)
Patents (480)
Patient recruitment (513)
Peanut (31)
People (41274)
Pharmaceutical (30)
Pharmacy benefit managers (8)
Phase 1 (15476)
Phase 2 (21394)
Phase 3 (14428)
Pipeline (7436)
Policy (18)
Postmarket research (1572)
Preclinical (6541)
Press Release (34)
Prostate cancer (191)
Psychedelics (7)
Radiopharmaceuticals (189)
Rare diseases (576)
Real estate (3021)
Recruiting (6)
Regulatory (14875)
Reports (21)
Research institute (583)
Resumes & cover letters (46)
Rett syndrome (42)
RNA editing (5)
RSV (48)
Schizophrenia (101)
Series A (157)
Series B (122)
Service/supplier (5)
Sickle cell disease (63)
Spinal muscular atrophy (88)
Sponsored (5)
Startups (2019)
Stomach cancer (3)
Supply chain (50)
Vaccines (330)
Venture capital (17)
Weight loss (73)
Women's health (82)
Date
Today (58)
Last 7 days (252)
Last 30 days (1483)
Last 365 days (18940)
2026 (12593)
2025 (19251)
2024 (22987)
2023 (26538)
2022 (34594)
2021 (37171)
2020 (33473)
2019 (23257)
2018 (17469)
2017 (18766)
2016 (17918)
2015 (24263)
2014 (21683)
2013 (18135)
2012 (20221)
2011 (20440)
2010 (20332)
Location
Africa (228)
Alabama (74)
Alaska (2)
Arizona (306)
Arkansas (11)
Asia (17918)
Australia (2099)
California (12052)
Canada (3170)
China (530)
Colorado (487)
Connecticut (413)
Delaware (208)
Europe (24652)
Florida (1805)
Georgia (385)
Hawaii (3)
Idaho (46)
Illinois (707)
India (51)
Indiana (316)
Iowa (15)
Japan (409)
Kansas (101)
Kentucky (31)
Louisiana (27)
Maine (26)
Maryland (1206)
Massachusetts (7896)
Michigan (308)
Minnesota (563)
Mississippi (4)
Missouri (82)
Montana (20)
Nebraska (11)
Nevada (117)
New Hampshire (60)
New Jersey (2633)
New Mexico (12)
New York (2828)
North Carolina (1291)
North Dakota (4)
Northern California (6043)
Ohio (280)
Oklahoma (14)
Oregon (18)
Pennsylvania (2265)
Puerto Rico (20)
Rhode Island (30)
South America (406)
South Carolina (77)
South Dakota (1)
Southern California (5008)
Tennessee (121)
Texas (1957)
United States (39112)
Utah (363)
Vermont (1)
Virginia (155)
Washington D.C. (38)
Washington State (933)
West Virginia (1)
Wisconsin (74)
Wyoming (1)
485,072 Results for "cynosure inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Cynosure Lutronic Redefines Skin Resurfacing with the Launch of the eCO2 3D Laser
October 2, 2025
·
3 min read
Genetown
Cynosure Partners with LaserAway® to Bring Potenza® RF Microneedling, a First-of-its-Kind Technology, to Consumers Nationwide
Cynosure announced it entered into partnership with LaserAway, the nation’s leader in aesthetic dermatology, to significantly expand access to Cynosure’s Potenza RF Microneedling system at all their locations nationwide.
January 16, 2024
·
3 min read
Press Releases
Cynosure Lutronic Announces Health Canada Clearance for XERF, the Future of Non-Invasive Skin Tightening
April 9, 2025
·
3 min read
Genetown
Cynosure Enters into Partnership Agreement with Jeisys Medical Japan
Cynosure LLC announced today that Cynosure KK (subsidiary of Cynosure LLC) has entered into a distribution partnership with Jeisys Medical KK (subsidiary of Jeisys Medical Inc.) in Japan.
March 18, 2022
·
2 min read
Genetown
Cynosure Upgrades State-of-the-Art PicoSure® System with PicoSure® Pro Device
Today Cynosure announced the launch of the PicoSure® Pro device, the latest upgrade to the company’s best-in-class PicoSure system.
June 1, 2022
·
4 min read
Genetown
Cynosure Announces $60 Million Follow-on Investment from Clayton, Dubilier & Rice to Accelerate Growth
Cynosure, LLC, a leader in medical aesthetics systems and technologies, announced today a new investment of $60 million from lead investor Clayton, Dubilier & Rice.
May 17, 2022
·
3 min read
Cynosure Announces Grand Opening of State-of-the-Art Experience Centre in London
Cynosure announced the grand opening of its new Cynosure Experience Centre in London.
May 17, 2021
·
3 min read
Press Releases
Tevogen Bio Holdings Inc. Becomes Tevogen Inc.
July 29, 2026
·
4 min read
Business
Cynosure Nabs Marketing Expert Katie Cheng As New Chief Marketing Officer
Cynosure announced today that Katie Cheng will join Cynosure as its new Chief Marketing Officer. With more than 25 years of diverse experience in consumer and professional brand and product marketing
January 4, 2021
·
3 min read
Deals
Cynosure to Acquire MyEllevate, Innovative Minimally Invasive Facial Rejuvenation Treatment
Cynosure announced today at The Aesthetic Society’s “The Aesthetic Meeting 2021" that it has entered into an agreement to acquire the MyEllevate® Surgical Suture System
April 30, 2021
·
3 min read
1 of 48,508
Next
